In this manuscript we report the synthesis, pharmacological evaluation and docking studies of a selected series of 3-aryl and 3-heteroarylcoumarins with the aim of finding structural features for the tyrosinase inhibitory activity. The synthesized compounds were evaluated as mushroom tyrosinase inhibitors. Compound 12b showed the lowest IC50 (0.19 μM) of the series, being approximately 100 times more active than kojic acid, used as a reference compound. The kinetic studies of tyrosinase inhibition revealed that 12b acts as a competitive inhibitor of mushroom tyrosinase with l-DOPA as the substrate. Furthermore, the absence of cytotoxicity in B16F10 melanoma cells was determined for this compound. The antioxidant profile of all the derivatives was evaluated by measuring radical scavenging capacity (ABTS and DPPH assays). Docking experiments were carried out on mushroom tyrosinase structures to better understand the structure-activity relationships.

Design and discovery of tyrosinase inhibitors based on a coumarin scaffold

FAIS, ANTONELLA;DI PETRILLO, AMALIA;PINTUS, FRANCESCA;ERA, BENEDETTA
2015-01-01

Abstract

In this manuscript we report the synthesis, pharmacological evaluation and docking studies of a selected series of 3-aryl and 3-heteroarylcoumarins with the aim of finding structural features for the tyrosinase inhibitory activity. The synthesized compounds were evaluated as mushroom tyrosinase inhibitors. Compound 12b showed the lowest IC50 (0.19 μM) of the series, being approximately 100 times more active than kojic acid, used as a reference compound. The kinetic studies of tyrosinase inhibition revealed that 12b acts as a competitive inhibitor of mushroom tyrosinase with l-DOPA as the substrate. Furthermore, the absence of cytotoxicity in B16F10 melanoma cells was determined for this compound. The antioxidant profile of all the derivatives was evaluated by measuring radical scavenging capacity (ABTS and DPPH assays). Docking experiments were carried out on mushroom tyrosinase structures to better understand the structure-activity relationships.
B16f10 melanoma cells; Mushroom tyrosinase; Radical scavenging capacities; Reference compounds; Structure activity relationships; Tyrosinase inhibition; Tyrosinase inhibitors; Tyrosinase inhibitory activities
File in questo prodotto:
File Dimensione Formato  
29_RSC Advances_2015.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 603.18 kB
Formato Adobe PDF
603.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
RSC Advances accepted manuscript 2015.pdf

accesso aperto

Tipologia: versione post-print
Dimensione 948.17 kB
Formato Adobe PDF
948.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/138431
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 41
social impact